J Siehler, AK Blöchinger, M Meier… - Nature reviews Drug …, 2021 - nature.com
Diabetes mellitus is a metabolic disorder that affects more than 460 million people worldwide. Type 1 diabetes (T1D) is caused by autoimmune destruction of β-cells, whereas …
SM Czerniecki, NM Cruz, JL Harder, R Menon, J Annis… - Cell stem cell, 2018 - cell.com
Organoids derived from human pluripotent stem cells are a potentially powerful tool for high- throughput screening (HTS), but the complexity of organoid cultures poses a significant …
A Rezania, JE Bruin, P Arora, A Rubin… - Nature …, 2014 - nature.com
Transplantation of pancreatic progenitors or insulin-secreting cells derived from human embryonic stem cells (hESCs) has been proposed as a therapy for diabetes. We describe a …
HA Russ, AV Parent, JJ Ringler, TG Hennings… - The EMBO …, 2015 - embopress.org
Directed differentiation of human pluripotent stem cells into functional insulin‐producing beta‐like cells holds great promise for cell replacement therapy for patients suffering from …
Three-dimensional (3D) printing, as one of the most popular recent additive manufacturing processes, has shown strong potential for the fabrication of biostructures in the field of tissue …
Diabetes is a chronic debilitating disease that results from insufficient production of insulin from pancreatic β-cells. Islet cell replacement can effectively treat diabetes but is currently …
V Tabar, L Studer - Nature Reviews Genetics, 2014 - nature.com
After years of incremental progress, several recent studies have succeeded in deriving disease-relevant cell types from human pluripotent stem cell (hPSC) sources. The prospect …
Human pluripotent stem cells (hPSCs) represent a renewable source of pancreatic beta cells for both basic research and therapeutic applications. Given this outstanding potential …
The behavior of stem cells, when they work collectively, can be much more sophisticated than one might expect from their individual programming. This Perspective covers recent …